[go: up one dir, main page]

AR027687A1 - Procedimiento para preparar camptotecina - Google Patents

Procedimiento para preparar camptotecina

Info

Publication number
AR027687A1
AR027687A1 ARP010101292A ARP010101292A AR027687A1 AR 027687 A1 AR027687 A1 AR 027687A1 AR P010101292 A ARP010101292 A AR P010101292A AR P010101292 A ARP010101292 A AR P010101292A AR 027687 A1 AR027687 A1 AR 027687A1
Authority
AR
Argentina
Prior art keywords
procedure
camptothecin
camptotechine
prepare
methoxycamptothecin
Prior art date
Application number
ARP010101292A
Other languages
English (en)
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of AR027687A1 publication Critical patent/AR027687A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere a la produccion a gran escala de camptotecina, que es el compuesto de partida del hidrocloruro de irinotecan y diversos derivados decamptotecina, a bajo costo y con facilidad. Se provee un procedimiento para preparar camptotecina, que comp rende las siguientes etapas: (a) la etapa dehidrolizar 9-metoxicamptotecina o un material natural que contiene 9-metoxicamptotecina; (b) la etapa de convertir 9-hidroxicamptotecina obtenida en la etapa(a) en camptotecina mediante 9-O-perfluoro-alquil o inferior-sulfonilacion o 9-O-feniltetrazolilacion, seguida de hidrogenolisis.
ARP010101292A 2000-03-22 2001-03-20 Procedimiento para preparar camptotecina AR027687A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000079385 2000-03-22

Publications (1)

Publication Number Publication Date
AR027687A1 true AR027687A1 (es) 2003-04-09

Family

ID=18596639

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101292A AR027687A1 (es) 2000-03-22 2001-03-20 Procedimiento para preparar camptotecina

Country Status (14)

Country Link
US (1) US6743918B2 (es)
EP (1) EP1270579B1 (es)
JP (1) JP4624633B2 (es)
KR (1) KR100757463B1 (es)
CN (1) CN1228341C (es)
AR (1) AR027687A1 (es)
AT (1) ATE327995T1 (es)
AU (2) AU2001242735B2 (es)
BR (1) BR0109343A (es)
CA (1) CA2402364C (es)
DE (1) DE60120139T2 (es)
MX (1) MXPA02009203A (es)
TW (1) TWI287016B (es)
WO (1) WO2001070747A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
TWI396690B (zh) 2006-04-27 2013-05-21 Yakult Honsha Kk 喜樹鹼衍生物的製造方法
CN108570057A (zh) * 2017-03-13 2018-09-25 烟台药物研究所 一种合成7-乙基-10-羟基喜树碱的方法
CN113880855A (zh) * 2021-09-02 2022-01-04 兰州大学 一种9-氟喜树碱衍生物的制备及其在抗肿瘤方面的用途
CN113880872A (zh) * 2021-09-02 2022-01-04 兰州大学 一种喜树碱硼酸类化合物的制备及其在抗肿瘤方面的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4496555A (en) * 1983-07-19 1985-01-29 Wayne State University Compounds and compositions for inhibiting estrogen sulfotransferase transferase activity, process and novel intermediates therein
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
JPS6185319A (ja) * 1984-10-03 1986-04-30 Yakult Honsha Co Ltd 抗腫瘍剤
WO1987004430A2 (en) * 1986-01-16 1987-07-30 Schering Corporation Fused benzazepines
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
JP2538792B2 (ja) 1987-06-25 1996-10-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US4868291A (en) * 1987-08-20 1989-09-19 Bristol-Myers Company 4'-deshydroxyepipodophyllotoxin glucosides: synthesis and use
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JPH0873461A (ja) 1994-09-06 1996-03-19 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体

Also Published As

Publication number Publication date
CN1228341C (zh) 2005-11-23
EP1270579A1 (en) 2003-01-02
JP4624633B2 (ja) 2011-02-02
CN1419558A (zh) 2003-05-21
TWI287016B (en) 2007-09-21
EP1270579B1 (en) 2006-05-31
KR100757463B1 (ko) 2007-09-11
KR20020087071A (ko) 2002-11-21
MXPA02009203A (es) 2004-04-02
CA2402364C (en) 2008-07-08
BR0109343A (pt) 2002-12-17
DE60120139D1 (de) 2006-07-06
ATE327995T1 (de) 2006-06-15
AU4273501A (en) 2001-10-03
CA2402364A1 (en) 2001-09-27
US6743918B2 (en) 2004-06-01
DE60120139T2 (de) 2007-04-12
AU2001242735B2 (en) 2005-05-26
US20040087609A1 (en) 2004-05-06
EP1270579A4 (en) 2004-07-07
WO2001070747A1 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
CR8358A (es) Pentalones transpuestos, un metodo para prepararlos y su uso como antiinflamatorios
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
GT200600213A (es) Metodos para sintetizar 3-cianoquinolinas sustituidas y sus intermediarios
NZ533179A (en) Hydroxycucurbituril derivatives, their preparation methods and uses
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
DK1603663T3 (da) Keramisk nanofiltrationsmembran til anvendelse i organiske opløsningsmidler og fremgangsmåde til deres fremstilling
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
NO20054614L (no) Fremgangsmate til fremstilling av 68Ga
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
ATE479688T1 (de) Herstellung von famciclovir und anderen purinderivaten
UY26133A1 (es) Derivado sustituido de pirazol.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR030735A1 (es) Un procedimiento para la produccion de un extracto de champinon natural
ECSP034754A (es) Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad
AR027687A1 (es) Procedimiento para preparar camptotecina
BR0016847A (pt) Composições fluidas contendo éster
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
AR032369A1 (es) Procedimiento para preparar 3-amino-2-cloro-4-metilpiridina
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten

Legal Events

Date Code Title Description
FG Grant, registration